Medical Condition News

RSS

Advancing precision medicine with functional information in cancer treatment

A new editorial was published in Volume 11 of Oncoscience on July 19, 2024, entitled, "Functional information offers individualized adaptive cancer therapies."

30 Aug 2024

Semaglutide's impact on cardiovascular health expands beyond weight loss

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19 related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC, the flagship journal of the American College of Cardiology.

30 Aug 2024

New ESC guidelines introduce intensive blood pressure targets and renal denervation recommendations

Updated ESC Guidelines on the management of elevated blood pressure and hypertension include a new elevated blood pressure category, more ambitious and intensive treatment targets, and, for the first time, recommendations on the use of renal denervation to treat various forms of hypertension.

30 Aug 2024

New ESC guidelines highlight broader approach to managing chronic coronary syndromes

The 2024 ESC Guidelines on the management of chronic coronary syndromes (CCS) include a focus on both larger and smaller blood vessels of the heart; new models to estimate chances of blocked large arteries (so-called obstructive coronary artery disease); optimal selection and sequence of tests; drugs and interventions to prevent disease complications and improve symptoms, and the fundamental role of patient involvement.

30 Aug 2024

Updated atrial fibrillation guidelines focus on risk management and patient-centered care

The 2024 ESC Guidelines for the management of atrial fibrillation, developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), contain a number of new approaches and treatment-specific recommendations to help manage the surging numbers of patients with AF worldwide.

30 Aug 2024

Major surgery complications unaffected by use of renin-angiotensin system inhibitors

There was no difference in major post-operative complications in patients who continued vs. stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

30 Aug 2024

Semaglutide lowers COVID-19-related deaths in cardiovascular patients with obesity

Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease without diabetes, according to a new study published in JACC, the flagship journal of the American College of Cardiology.

30 Aug 2024

Introducing a blood-based test for minimally invasive detection of IDH1 mutant gliomas

Glioma represents the most common central nervous system cancer in adults. The current classification scheme uses molecular alterations, particularly IDH1.R132H, to stratify lesions into distinct prognostic groups.

30 Aug 2024

Vutrisiran shows potential to become the new standard of care for rare heart disease

Vutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

30 Aug 2024

New ESC guidelines integrate management of aortic and peripheral arterial diseases

The 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate these vascular diseases together as part of same cardiovascular system, appreciating that patients with aortic diseases are at risk of having peripheral vascular diseases and vice versa.

30 Aug 2024

ESC consensus statement highlights obesity's impact on cardiovascular disease

The ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year's ESC Congress (London, UK, 30 August to 2 September) summarizes current evidence on the epidemiology and etiology of obesity; the interplay between obesity, cardiovascular risk factors and cardiac conditions; the clinical management of patients with cardiac disease and obesity; and weight loss strategies including lifestyle changes, interventional procedures, and anti-obesity medications with particular focus on their impact on cardiometabolic risk and cardiac outcomes.

30 Aug 2024

New finger-prick blood test could revolutionize Alzheimer’s screening

GPs could soon be able to screen their patients for Alzheimer’s Disease (AD) using a simple handheld device developed by Monash engineers.

30 Aug 2024

First-generation antihistamine drugs could increase seizure risk among young children

Research indicates first-generation antihistamines may elevate seizure risk in young children, highlighting the need for careful prescription practices.

30 Aug 2024

Benchmark Genetics Iceland remains unaffected by the ongoing volcanic eruption

Our facilities are situated outside the designated risk zone for the current seismic and volcanic activities near Grindavík, Iceland.

From Benchmark Genetics 30 Aug 2024

Obesity increases the risk of SARS-CoV-2 infection by 34%

Obesity is linked to a 34% higher risk of SARS-CoV-2 infection upon exposure, highlighting the importance of weight management in COVID-19 prevention.

30 Aug 2024

Study finds geographic variations in concussion diagnoses across U.S. emergency departments

Researchers in Michigan State University's Department of Kinesiology found significant geographic variations in concussion diagnoses in United States emergency departments -; with the highest rates in the South and lower rates in the Midwest and Northeast.

29 Aug 2024

CBL identified as the most promising potential biomarker for aortic dissection

Previous
1
...
79
80
81
82
83
84
85
...
5486
Next

Medical Condition News

Advancing precision medicine with functional information in cancer treatment

Semaglutide's impact on cardiovascular health expands beyond weight loss

New ESC guidelines introduce intensive blood pressure targets and renal denervation recommendations

New ESC guidelines highlight broader approach to managing chronic coronary syndromes

Updated atrial fibrillation guidelines focus on risk management and patient-centered care

Major surgery complications unaffected by use of renin-angiotensin system inhibitors

Semaglutide lowers COVID-19-related deaths in cardiovascular patients with obesity

Introducing a blood-based test for minimally invasive detection of IDH1 mutant gliomas

Vutrisiran shows potential to become the new standard of care for rare heart disease

New ESC guidelines integrate management of aortic and peripheral arterial diseases

ESC consensus statement highlights obesity's impact on cardiovascular disease

New finger-prick blood test could revolutionize Alzheimer’s screening

First-generation antihistamine drugs could increase seizure risk among young children

Benchmark Genetics Iceland remains unaffected by the ongoing volcanic eruption

Obesity increases the risk of SARS-CoV-2 infection by 34%

Study finds geographic variations in concussion diagnoses across U.S. emergency departments

CBL identified as the most promising potential biomarker for aortic dissection

Fibrin fuels thromboinflammation and brain damage in COVID-19

Probenecid shows promise for easing opioid withdrawal symptoms in new study

Discovery of borderzone inflammation offers new avenues for heart failure prevention

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News